OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: multikine

CEL-SCI Corporation (AMEX: CVM) Remains an Intriguing Bet for Investors Interested in Biotech’s Treatment for Head and Neck Cancer

Posted on February 7, 2012 by Editor

With the dust settling following last month’s financing deal in which CEL-SCI Corporation (AMEX: CVM) sold 16,000,000 shares of its common stock to institutional investors for $5,760,000 or $0.36 per share, along with those institutional investors receiving Series H warrants … Continue reading →

Posted in AMEX, Articles | Tagged , , , , , , , , , | Leave a comment

CEL-SCI Corporation (AMEX: CVM) Lagging as Phase III Trial for Cancer Therapy Multikine Continues to Drag

Posted on September 12, 2011 by Editor

Trying to follow the progress of CEL-SCI Corporation (AMEX: CVM) and the Phase III trial testing their cancer therapy Multikine as a treatment for newly diagnosed head and neck cancer patients can be a painful process for shareholders as the … Continue reading →

Posted in AMEX, Articles, Penny Stocks | Tagged , , , , , , , , | Leave a comment

CEL-SCI Corporation Inching Closer Toward Phase III Clinical Trial of Multikine but Investors Remain Skeptical

Posted on October 29, 2010 by Editor

It’s hard to image a biotechnology company entering a Phase III clinical trial to test an immunotherapy for head and neck cancer would be trading in the 0.68 – 0.71 range but that is exactly where CEL-SCI Corporation (AMEX: CVM) … Continue reading →

Posted in AMEX, Articles | Tagged , , , , , , , , , , | Leave a comment